
Crossject S.A (ALCJ) | Stock Overview & Key Data
Crossject S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €13.09 on February 24, 2014
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Crossject S.A ALCJ | 85.42M Small-cap | 1.82% | 3.07% | 0.00% | -5.08% | -25.00% | -28.51% | -56.70% | -55.79% |
EssilorLuxottica EL | 123.50B Large-cap | 3.38% | 11.70% | 4.45% | -6.50% | 16.14% | 26.57% | 79.07% | 139.75% |
Sartorius Stedim DIM | 17.27B Large-cap | -0.40% | -7.43% | -11.07% | -13.75% | -4.75% | -0.65% | -53.41% | -40.52% |
Visiomed Group SA ALVMG | 53.17M Small-cap | 5.00% | 16.67% | 16.67% | 0.00% | 23.53% | 23.53% | -48.78% | -80.19% |
Bonyf N.V MLBON | 7.77M Small-cap | 0.00% | 0.00% | -18.35% | -33.51% | -28.33% | -19.38% | 7.50% | 3.20% |
Spineway S.A ALSPW | 4.61M Small-cap | 0.00% | 8.33% | 8.33% | 0.00% | 44.44% | 8.33% | 8.33% | 8.33% |
Ownership & Short Interest
Crossject S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Crossject S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALCJ's 52-week high and low?
- In the last 52 weeks, Crossject S.A reached a high of €2.75 (on October 22, 2024) and a low of €0.72 (on April 11, 2025).
- What is the market cap and P/E ratio for ALCJ?
- Curious about Crossject S.A's size and valuation? Its market capitalization stands at 85.42M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is 7.65.
- Does ALCJ pay dividends? If so, what's the yield?
- As for dividends, Crossject S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Crossject S.A's main competitors or similar companies to consider before investing?
When looking at Crossject S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return EssilorLuxottica
EL123.50B Healthcare Medical Instruments & Supplies 26.57% 79.07% Sartorius Stedim
DIM17.27B Healthcare Medical Instruments & Supplies -0.65% -53.41% Visiomed Group SA
ALVMG53.17M Healthcare Medical Instruments & Supplies 23.53% -48.78% Bonyf N.V
MLBON7.77M Healthcare Medical Instruments & Supplies -19.38% 7.50% Spineway S.A
ALSPW4.61M Healthcare Medical Instruments & Supplies 8.33% 8.33% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Crossject S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Crossject S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 478.68%, the Debt to Equity ratio from the most recent quarter is -7.88, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALCJ?
- Looking at Crossject S.A's growth, its revenue over the trailing twelve months (TTM) was €4M. Compared to the same quarter last year (YoY), quarterly revenue grew by 227.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALCJ stock is held by insiders and institutions?
- Wondering who owns Crossject S.A stock? Company insiders (like executives and directors) hold about 19.81% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.18%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.